Dr. Hin Hin Ko, MD
Claim this profileSt. Paul's Hospital
Studies Primary Biliary Cirrhosis
Studies Autoimmune Hepatitis
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Hin Hin Ko, MD is currently running
EP-104IAR
for EoE
This trial tests a new drug, EP-104IAR, in adults with eosinophilic esophagitis (EoE). The drug is given during an endoscopy to see if it can reduce inflammation and symptoms in the esophagus.
Recruiting0 awards Phase 1 & 2
Observational Study
for Autoimmune Hepatitis
CaNAL is a longitudinal observational cohort study of patients diagnosed with Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH), or overlap syndrome. This study creates a nationwide registry and network focusing on high quality long-term follow-up of individual patient data from major Canadian centers. Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) are rare and slowly progressive liver diseases associated with development of cirrhosis, liver cancer (HCC) and liver failure requiring liver transplantation or leading to premature death. The rarity and slowly progressive nature of these autoimmune liver diseases make them difficult to study and only a large scale approach combining patient data from multiple centers across Canada will allow new insights. The primary aim of the Canadian Network for Autoimmune Liver Disease is to build a Canadian registry of patients with PBC, AIH, and overlap syndrome. We capture patient characteristics, laboratory assessments and natural history, patient-reported outcomes including quality of life measures and environmental exposures, response to treatment, and pre- and post-transplant outcomes. We will then identify risk factors associated with critical outcomes for the patient, including response to treatment, progression to transplant, risk of liver cancer, and recurrent disease after transplant. We can identify biomarkers (biochemical indicators of progression of disease) to help diagnose autoimmune liver disease at its earliest stages, ensuring timely treatment and preventing disease progression. CaNAL will provide a better understanding of autoimmune liver diseases, biomarkers predictive of disease progression or non-response to therapy as well as better knowledge of the etiology and pathogenesis. CaNAL will also help to serve as a platform for conducting clinical trials or targeted lab-studies to answer important questions that are unlikely to be evaluated by the pharmaceutical industry.
Recruiting1 award N/A1 criteria
More about Hin Hin Ko, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Hin Hin Ko, MD has experience with
- Observational
- EP547
- EP-104IAR
Breakdown of trials Hin Hin Ko, MD has run
Primary Biliary Cirrhosis
Autoimmune Hepatitis
Overlap Syndromes
Primary Sclerosing Cholangitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hin Hin Ko, MD specialize in?
Hin Hin Ko, MD focuses on Primary Biliary Cirrhosis and Autoimmune Hepatitis. In particular, much of their work with Primary Biliary Cirrhosis has involved treating patients, or patients who are undergoing treatment.
Is Hin Hin Ko, MD currently recruiting for clinical trials?
Yes, Hin Hin Ko, MD is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Hin Hin Ko, MD has studied deeply?
Yes, Hin Hin Ko, MD has studied treatments such as Observational, EP547, EP-104IAR.
What is the best way to schedule an appointment with Hin Hin Ko, MD?
Apply for one of the trials that Hin Hin Ko, MD is conducting.
What is the office address of Hin Hin Ko, MD?
The office of Hin Hin Ko, MD is located at: St. Paul's Hospital, Vancouver, British Columbia V6Z 1Y6 Canada. This is the address for their practice at the St. Paul's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.